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Abstract
Background: A recent genome-wide scan has identified two genetic variants in the HLA-DP region strongly associated with
hepatitis B infection in Japanese. This study evaluates the effects of these risk variants in Chinese, where the HBV infection is
the most popular in the world.
Methods and Findings: We have assessed the relationship between these two single nucleotide polymorphisms (rs3077
and rs9277535) and chronic hepatitis B infection in two independent case-control studies. The first population in Chinese
Han included 736 patients and 782 spontaneously recovered controls. The second set was established in Chinese Zhuang
minority of 177 patients and 208 controls. Both A alleles of rs3077 and rs9277535 significantly deceased the risk to CHB in
Chinese Han (OR=0.540, 95%CI: 0.464–0.628, P=4.068610
216 and OR=0.696, 95%CI: 0.601–0.806, P=1.062610
26,
respectively). Conceivably, rs9277535 was found to be associated with decreased risk of the disease in Chinese Zhuang, with
an OR of 0.606 (95%CI, 0.441–0.833, P=0.002).
Conclusion: Chronic hepatitis B susceptibility loci in HLA-DP region (rs3077 and rs9277535) identified by genome-wide scan
in Japanese population were validated in Chinese population. These findings might provide clues to develop screening and
surveillance strategies.
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Introduction
Hepatitis B virus (HBV) infection is the most common cause of
liver disease, with around 2 billion people infected and 350 million
suffering from chronic HBV infection worldwide [1]. Its
prevalence shows a regional diversity, with relative low-incidence
in Western countries but endemic in China [2], where a national
survey reported roughly 7.18% rate of HBsAg carriers in the
general population, indicating more than one-third of the world’s
HBV carriers live in China [3]. The clinical outcome of HBV
infection is also variable, from spontaneously recovery to persistent
infection that may increasingly progress to cirrhosis and
hepatocellular carcinoma. It is estimated that more than 300,000
people die from HBV-related diseases in China annually,
including 180,000 patients with hepatocellular carcinoma, which
is associated with increased healthcare challenge and other
socioeconomic burdens. The mechanisms underlying the different
clinical outcomes of HBV infection have not been fully
understood. Although environmental factors such as viral strain,
gender, infection age and immune status of the host were
suspected to affect risk of chronic hepatitis B (CHB) [4], there
were evidence strongly suggested that host genetic factors [5–7]
may play an important role in the occurrence of CHB. Less than
20% people exposed to HBV develop to CHB, and only a fraction
of exposed people actually develops serious clinical sequelae, such
as cirrhosis and and hepatocellular carcinoma, during their
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development of CHB [6] and a strong selection in genetic
evolution limit its prevalence. Additional, familial studies indicated
that monozygotic twins, dizygotic twins and general control may
suffer from infection outcome differently and female sibling may
have more chance to develop natural immunity and recover easily
[5].
During the past decades, researchers have paid much attention
to genetic polymorphisms (SNPs) in both human leukocyte antigen
(HLA) genes and some other genes which modulate or control
immune response to HBV infection. For example, accumulating
evidence, including our former studies, has demonstrated that
SNPs in tumor necrosis factor-alpha [8–13], vitamin D receptor
gene [13–15] and HLA-DR1 [11,16–20] may be associated with
the outcomes of HBV infections. However, most of the results
from previous studies so far remain inconsistent due to disparities
in ethnicity, sample size and genotyping techniques.
Most recently, a two-stage genome-wide association (GWAS)
study using 786 Japanese CHB and 2201 controls was performed
by Kamatani Y et al., then the identified SNPs, including rs3077
and rs9277535 located in HLA-DPA1 and DPB1, were validated
in three additional Japanese and Thai cohorts consisting 1300
patients and 2100 controls [21]. HLA-DPA1 and HLA-DPB1
encode the HLA-DP alpha and beta chains and may be implicated
in antigen presentation to CD4
+ positive T lymphocyte, which is
important for HBV clearance, whiles the clear mechanism still
needs to be verified. Moreover, the data of HBV exposure of
controls selected in aforementioned GWAS study was not
complete, which may introduce information bias to interpret the
results.
Therefore, we sought to investigate and extend our under-
standing of the effect of these two recently identified SNPs in the
risk of CHB in two large independent populations with different
infection rate of HBV, one from Northern Chinese Han and
another from Southern Chinese Zhuang, respectively in this study.
Importantly, each population in this study included CHB patients
and individuals spontaneously recovered to ensure all the subjects
have the history of HBV exposure.
Methods
Study population and design
Two different populations were enrolled in this study; the first
population was unrelated Han ethnicity, recruited from Beijing,
Northern China and second one was unrelated Zhuang Chinese,
from Southern China. Each population was composed of two
subgroups: spontaneously recovered individuals with history of
HBV infection and CHB patients, according to serologic tests,
HBV virological index, liver function indexes and symptoms of
hepatitis B. The subject was diagnosed as chronic HB when his/
her serum levels of alanine aminotransferase and asparate
aminotransferase were continuously abnormal, and HBsAg was
seropositive and anti-HBs were seronegative after six months of
acute infection. The criteria of spontaneously recovered infection
were as follows: positive for both anti-HBs and anti-HBc
antibodies, definitely negative for HBsAg, normal liver functional
tests, and no history of acute/chronic hepatitis B and HBV
vaccination.
The Han population included 1518 Han subjects, among which
736 CHB patients were from Beijing Ditan Hospital and Beijing
You’an Hospital during the period of November 2001 to August
2004 and 782 spontaneously recovered subjects who were
screened from ,5000 individuals from serological investigation
on HBV infection in Beijing, 2006 [22]. The Chinese Zhuang was
composed of 177 CHB patients and 208 spontaneously recovered
subjects, who were randomly selected from serological investiga-
tion on HBV infection in Southern China, 2006. Written informed
consent was obtained from each subject. The Institutional Review
Board at the Institute of Medical Sciences, Chinese Academy of
Medical Sciences approved the study.
Serological testing
Enzyme-linked immunoadsorbent assay was used to detect the
serum HBsAg, anti-HBs and anti-HBc (IMX; Abbott Diagnostics,
North Chicago, IL, USA).
Polymorphism genotyping
Genomic DNA was extracted from blood sample of all subjects
by using QIAamp-Blood Kit (Qiagen, Hilden, Germany). All the
subjects were genotyped using TaqMan Genotyping system
(Applied Biosystems, Foster City, CA) without knowledge of the
subjects’ infection status. PCR was performed using TaqMan
Universal Master Mix on the Bio-Rad iQ
TM5 Real-Time PCR
Detection System (Bio-Rad Laboratories, Hercules, CA) and the
program was heating to 95uC for 10 minutes followed by 40 cycles
of 92uC for 15 seconds and 60uC for 1 minute. Fifteen percent of
the masked sample was randomly selected and genotyped twice by
different people independently. The reproducibility was 100%.
Statistical analysis
Chi-square test was also used to compare the allele and
genotype frequencies of the two SNPs between CHB patients and
spontaneously recovered individuals in each population. The odds
ratios (ORs) and their 95% confidence interval (CI) were
calculated to estimate the associations between the genotype and
the risk of infection status using logistic regression model. All of
above statistical analyses were performed using Statistical Analysis
System software (version 9.13; SAS Institute, Cary, NC). PHASE
v2.1 [23] was used to estimate the haplotype frequencies
composed of two SNPs and their difference in CHB and
spontaneously recovered individuals was calculated using chi-
square test as well. Estimation of LD, including r
2 and D’, and
haplotype association analyses were conducted using Haploview
[24].
Results
Study population
All the subjects in this study had the history of HBV exposure.
The Chinese Han population consisted of 1518 subjects (1,000
males and 518 females) and their mean age was 39.4614.3 years.
And the Chinese Zhuang was comprised of 385 individuals (235
males and 150 females) and their mean age was 40.3611.6. No
significant gender difference between the CHB and spontaneously
recovered individuals in both populations. However, the sponta-
neously recovered individuals (mean age: 43.2615.6) was
significantly older than the CHB patients (mean age: 35.5611.6)
in Han ethic groups (P,0.0001), and vice versa in Zhuang ethic
groups (41.2611.6 vs. 39.4611.5, P=0.146), respectively. The
details were shown in Table 1.
Association between frequency of rs3077 and rs9277535
and clinical outcomes of HBV infection
The results of each SNPs association analysis are summarized in
table 2. We found that A allele of rs3077 was less frequent in CHB
patients than in spontaneously recovered subjects among the Han
population (28.1% vs. 42.8%, P=3.714610
217). The same trend
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didn’t reach statistically significance (P=0.206). Intriguingly, A
allele of rs9277535 also showed a significantly protect effect
against CHB not only in Chinese Han but also in Chinese
Zhuang, with 35.8% and 44.6% in CHB and spontaneously
recovered subjects in Han Chinese (P=8.828610
27) and 23.4%
and 34.0% in Chinese Zhuang (P=0.001), respectively. In
addition, the frequency of A allele in spontaneously recovered
subjects was significantly lower in Chinese Zhuang than in
Chinese Han both for rs3077 (23.6% vs. 42.8%) and rs9277535
(33.9% vs. 44.6%), with the p values of 8.621610
213 and
8.217610
215, respectively, which may partially explain the
different prevalence of CHB in these two population.
Logistic regression model was subsequently used to determine
the two SNPs’ effects. Among Chinese Han groups, the subjects
with at least one A allele of rs3077 had a decreased risk to CHB
compared with the subjects with GG genotype (OR=0.540,
95%CI: 0.464–0.628, P=4.068610
216). And the same trend was
observed in rs9277535 (OR=0.696, 95%CI: 0.601–0.806,
P=1.062610
26). Similarly, in Chinese Zhuang groups, the
subjects carrying at least one A allele of rs9277535 also protect
against the CHB compared with GG carriers (OR=0.606,
95%CI: 0.441–0.833, P=0.002), but not the same with rs3077,
which was not observed significantly difference between the CHB
and spontaneously recovered subjects.
Since the prevalence of HBsAg is significantly higher for males
(8.6%) than females (5.7%), stratified analysis was used to test the
association of these two SNPs and CHB in males and females,
separately, but no significant difference was observed (data not
shown).
We further constructed the haplotype composing of the rs3077
and rs9277535 (data was shown in Table 3) and found that
individuals carrying haplotype A-A had the lowest risk of CHB
compared with G-G haplotype both in Chinese Han and Chinese
Zhuang. Moreover, strong linkage disequilibrium was not detected
between these two SNPs, with the D’ and r
2 equaling 0.569 and
0.265 in Chinese Han, and 0.408 and 0.113 in Chinese Zhuang,
respectively.
Discussion
The nature history of HBV infection is complicated and it is
necessary to find clinical and genetic markers to aid in prediction
of those who will have a higher risk to develop CHB and worse
outcomes, such as liver cirrhosis and HCC. Accumulating
evidence indicated that individuals who will clear HBV infection
have a low risk of viral persistence [25]. Clearance of HBV
infection is associated with vigorous CD4
+ T cells [26] and HLA
class II glycoprotein presenting viral peptide to CD4
+ T cells and
considered to be critical for the immune response [4,17,18,26–28],
Table 1. Characteristics of the subjects from two case-control studies.
Han Chinese Zhuang Chinese
Total (%) Cases (%) Controls (%) P Total (%) Cases (%) Controls (%) P
1518 736 782 385 177 208
Age at enrollment, years 39.4614.3 35.5611.6 43.2615.6 ,0.0001 40.3611.6 41.2611.6 39.4611.5 0.146
Gender
Male 1000 (65.9) 492 (66.9) 508 (65.0) 0.439 235 (61.0) 101 (57.1) 134 (64.4) 0.140
Female 518 (34.1) 244 (33.2) 274 (35.0) 150 (39.0) 76 (42.9) 74 (35.6)
doi:10.1371/journal.pone.0017608.t001
Table 2. The association between rs3077 and rs9277535 and the outcomes of HBV infection.
SNP ID Han ethnicity Zhuang ethnicity
Chronic
HB (%)
Spontaneously
recovered
subjects (%) OR (95% CI) P
Chronic
HB (%)
Spontaneously
recovered
subjects (%) OR (95% CI) P
rs3077
GG 391 (53.1) 262 (33.5) 115 (65.0) 125 (60.1)
AG 276 (37.5) 371 (47.4) 0.540 (0.464–0.628)
{ 4.068610
216 54 (30.5) 68 (32.7) 0.811 (0.580–1.135)
{ 0.221
AA 69 (9.4) 149 (19.1) 8 (4.5) 15 (7.2)
A allele 414 (28.1) 669 (42.8) 0.523 (0.450–0.609)
{ 3.714610
217 70 (19.7) 98 (23.6) 0.800 (0.566–1.130)
{ 0.206
rs9277535
GG 306 (41.6) 239 (30.6) 104 (58.8) 93 (44.7)
AG 332 (45.1) 388 (49.6) 0.696 (0.601–0.806)
{ 1.062610
26 63 (35.6) 89 (42.8) 0.606 (0.441–0.833)
{ 0.002
AA 98 (13.3) 155 (19.8) 10 (5.7) 26 (12.5)
A allele 528 (35.8) 698 (44.6) 0.694 (0.600–0.803)
{ 8.828610
27 83 (23.4) 141 (33.9) 0.597 (0.434–0.822)
{ 0.001
{Additive model was used to estimate the OR with GG genotype as the reference;
{G allele was used as reference.
doi:10.1371/journal.pone.0017608.t002
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implicated in the clinical outcomes of HBV infection.
Nevertheless, the effect of HLA genes on the HBV persistent
infection remains contradictory. The recent GWAS study has
identified two SNPs located at HLA-DP are associated with CHB
in Japanese [21]. HLA loci are among the most polymorphic in
the human genome and even the same HLA loci, the frequency of
allele may have much difference among diverse populations. So it
is important to validate the effects of above SNPs among different
population which may deepen our understanding of the genetic
susceptibility of CHB in different population.
Identification of genetic risk factors of CHB in Chinese is
especially crucial since China is the one of the highest prevalence
area in the world. Intriguingly, even in China, the rate of CHB is
also diverse among different regions and different ethnic
populations. Epidemiological studies reported that the prevalence
rate of HBsAg positive of Chinese Han in Beijing is relative low
(3.49%) [29], while Chinese Zhuang had the highest HBsAg
prevalence (13.4%) [3]. We therefore selected these two ethnic
populations to evaluate the association between these two SNPs
and the clinical outcomes of HBV exposure. We found the
protection effect of the A allele of both rs3077 and rs9277535 in
the risk of CHB in Chinese Han, which is consistent with the
results from Japanese GWAS study. However, only rs9277535 was
shown to be significantly associated with reduced risk of CHB in
Chinese Zhuang. The reason that the positive findings in Japanese
can be completely and partly repeated in our Northern Chinese
Han and Southern Chinese Zhuang respectively may be explained
by the share considerable proportion of genetic components with
Japanese [30]. According to a recent genome-wide study of genetic
diversity of Asian populations [30], Northern Chinese Han is the
one closely related to Japanese except Korean on the phylogenetic
tree and Zhuang is more southern compared with Japanese which
is typical representative of northern population. And another
reason for the non-significantly protection effect of rs3077 in
Chinese Zhuang may be due to the small sample for Chinese
Zhuang in this study. Since the sample from Chinese Zhuang only
included 177 CHB and 208 spontaneously recovered subjects, it
had only 14.4% power to detect an OR of 0.8 under the A allele
frequency of 0.236.
It has been well documented that the prevalence of HBV
infection is much higher in Asian than in Europeans. Conceivably,
the diverse frequency analysis in HapMap dataset demonstrated
that the protective A allele of rs9277535 was significantly higher in
European population (0.739) than in Beijing Han population
(0.463). Moreover, we found that the frequencies of both A allele
of rs3077 and rs9277535 in Chinese Han were similar with those
reported in Beijing Han of HapMap, while much higher than the
counterparts of Chinese Zhuang in Guangxi. These results were
consistent with the epidemiological data, indicating the higher
infection rate of HBV in Zhuang may partially due to lower
frequencies of these two SNPs. It is worth mentioning that just
when this manuscript was preparing, Guo and colleagues reported
genetic variants in the HLA-DP locus were strongly associated
with persistent HBV infection in the Han Chinese population,
which was consistent with our finding [31].
The rs3077 and rs9277535 locate at the 39-untranslated regions
(UTR) of HLA DPA1 and DPB1, respectively, which belong to the
third set of classical HLA class II loci coding for the DP alpha and
beta chains and may play substantial roles in antigen presentation
to CD4
+ positive T lymphocyte. Studies have shown that HLA-
DPs are highly polymorphic, with 28 DPA1 and 138 DPB1 alleles
till now (http://www.ebi.ac.uk/imgt/hal/). Functional analysis of
HLA-DP polymorphisms in the coding region suggested that DPb
residues 9, 11, 35, 55, 56, 69 and 84–87 play a key role in T cell
allorecognition and peptide binding [32] and the DPA1 allele
difference has been observed to significantly alter T cell
recognition [33]. Also, a single K to E difference at position 69
of DPB1 was found to influence T cell recognition [32,34]. All
above evidence supports that the genetic polymorphisms in HLA
DP region may result in the variable capacity of antigen
presentation and influence the outcomes of Hepatitis B infection
finally.
In terms of function of rs3077 and rs9277535, the clear
mechanism is still unknown. Both rs3077 and rs9277535 locate at
the 39-UTR of HLA-DPA1 and DPB1 gene, respectively, their
SNPs are impossible to affect the antigen-binding site directly. But
they may be the binding site of some microRNA (miRNA), a
group of short non-coding RNAs involved in post-transcriptional
regulation of gene expression by base paring with target mRNAs
at the 39-UTR, leading to affect both the stability and translation
of mRNA. SNPs located at miRNA-binding site are likely to
disrupt miRNA-target interaction, and result in the deregulation of
target gene expression [35]. Alternatively, these two SNPs may
have strong LD with other SNPs which can influence the capacity
of antigen presentation in the coding region since they have long
LD with other SNPs in HLA-DP region in Chinese Han according
to HapMap data (data not shown), acting as a marker of other
potentially functional loci. Nonetheless, further functional analysis
of HLA-DP region, including these two SNPs, still needs to be
clarified.
Our study has several strengths. Firstly, we use the two
independently populations with different HBV infection rate to
do the replication and validation, which rigorously strength the
plausibility of this study [36,37]. Secondly, spontaneously
recovered individuals but not general population was selected as
controls to ensure all the subjects in the study having the history of
HBV exposure, reducing the selection bias of study. Moreover, all
Table 3. Comparison of haplotype frequencies between CHB patients and controls.
Han ethnicity Zhuang ethnicity
Haplotype (rs3077–
rs9277535)
Chronic
HB (%)
Spontaneously
recovered
subjects (%)
OR
(95% CI) P
Chronic
HB (%)
Spontaneously
recovered
subjects (%)
OR
(95% CI) P
GG 848 (57.6) 680 (43.5) 1.00 235 (66.4) 246 (57.7) 1.00
GA 210 (14.3) 215 (13.8) 0.783 (0.632–0.971) 0.026 49 (13.8) 72 (18.8) 0.642 (0.430–0.957) 0.030
AG 96 (6.5) 186 (12.0) 0.414 (0.317–0.540) 3.430610
211 36 (10.2) 29 (8.4) 1.050 (0.638–1.730) 0.847
AA 318 (21.6) 483 (30.9) 0.528 (0.444–0.628) 4.400610
213 34 (9.6) 69 (15.1) 0.551 (0.350–0.868) 0.010
doi:10.1371/journal.pone.0017608.t003
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but not hospital based enrolled. They were screened from
serological investigation on HBV infection among general
population in Beijing or Southern China in 2006 and showed
good representativeness. Thirdly, we can ensure our genotyping is
accurate since the allele frequency of these two SNPs in our Han
Chinese is comparable to those reported in Beijing Han of
HapMap data, with similar LD of these two SNPs in our study
(D’=0.569, r
2=0.265) with those from HapMap (D’=0.574,
r
2=0.245). Notwithstanding, the case-control population from
Chinese Zhuang was not statistically enough, which may lead to
the false-negative results of rs3077.
In conclusion, our study support that rs3077 and rs9277535 is
significantly related to HBV persistent infection and both A alleles
of these two SNPs are protection alleles, which are in accord with
the previous results from Japanese. These findings might provide
further evidence for the importance of the HLA’s role in HBV
infection and provide potential implications for therapeutic
guidance. However, further function analyses were warranted to
validate the biological plausibility of these two SNPs in hepatitis B
infection.
Author Contributions
Conceived and designed the experiments: LW XW WZ XM YL HL.
Performed the experiments: LW XW WZ DZ YW YL. Analyzed the data:
LW XW WZ DZ YW YL RL YT ZL XZ. Contributed reagents/
materials/analysis tools: LW XW WZ DZ YW YL RL YT ZL XZ JL JC.
Wrote the manuscript LW XW.
References
1. Liaw YF, Chu CM (2009) Hepatitis B virus infection. Lancet 373: 582–592.
2. Liu J, Fan D (2007) Hepatitis B in China. Lancet 369: 1582–1583.
3. Liang X, Bi S, Yang W, Wang L, Cui G, et al. (2009) Epidemiological serosurvey
of hepatitis B in China–declining HBV prevalence due to hepatitis B
vaccination. Vaccine 27: 6550–6557.
4. Wang FS (2003) Current status and prospects of studies on human genetic alleles
associated with hepatitis B virus infection. World J Gastroenterol 9: 641–644.
5. Lin TM, Chen CJ, Wu MM, Yang CS, Chen JS, et al. (1989) Hepatitis B virus
markers in Chinese twins. Anticancer Res 9: 737–741.
6. Pungpapong S, Kim WR, Poterucha JJ (2007) Natural history of hepatitis B virus
infection: an update for clinicians. Mayo Clin Proc 82: 967–975.
7. Thursz M (2001) Genetic susceptibility in chronic viral hepatitis. Antiviral Res
52: 113–116.
8. Du T, Guo XH, Zhu XL, Li JH, Lu LP, et al. (2006) Association of TNF-alpha
promoter polymorphisms with the outcomes of hepatitis B virus infection in
Chinese Han population. J Viral Hepat 13: 618–624.
9. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, et al. (2006) Association
between chronic hepatitis B virus infection and interleukin-10, tumor necrosis
factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol 21:
1163–1169.
10. Zheng MH, Qiu LX, Xin YN, Pan HF, Shi KQ, et al. (2010) Tumor necrosis
factor-alpha-308A allele may have a protective effect for chronic hepatitis B
virus infection in Mongoloid populations. Int J Infect Dis 14: e580–585.
11. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N (2007) Association
of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of
chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai
population. J Viral Hepat 14: 841–848.
12. Li HQ, Li Z, Liu Y, Li JH, Dong JQ, et al. (2006) Association of-238G/A and -
857C/T polymorphisms of tumor necrosis factor-alpha gene promoter region
with outcomes of hepatitis B virus infection. Biomed Environ Sci 19: 133–136.
13. Suneetha PV, Sarin SK, Goyal A, Kumar GT, Shukla DK, et al. (2006)
Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta
gene polymorphisms and HBV infection and severity of liver disease. J Hepatol
44: 856–863.
14. Huang YW, Liao YT, Chen W, Chen CL, Hu JT, et al. (2010) Vitamin D
receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B
carriers in Taiwan. Genes Immun 2010;11: 87–93.
15. Li JH, Li HQ, Li Z, Liu Y, Gao JR, et al. (2006) [Association of Taq I T/C and
Fok I C/T polymorphisms of vitamin D receptor gene with outcome of hepatitis
B virus infection]. Zhonghua Yi Xue Za Zhi 86: 1952–1956.
16. Lu LP, Li XW, Liu Y, Sun GC, Chen ZH, et al. (2006) [Association of haplotype
formed on HLA-DRB1 and HLA-DQA1 alleles with outcomes of hepatitis B
virus infection]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 427–430.
17. Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M,
et al. (2008) Association of human leukocyte antigen polymorphism with
outcomes of hepatitis B virus infection. J Gastroenterol Hepatol 23: 1716–1721.
18. Thursz MR, Kwiatkowski D, Allsopp CE, Greenwood BM, Thomas HC, et al.
(1995) Association between an MHC class II allele and clearance of hepatitis B
virus in the Gambia. N Engl J Med 1995;332: 1065–1069.
19. Xun YH, Guo JC, Shi WZ, Shi JP, Liu CL (2009) [Association between HLA-
DQA1 gene polymorphism and the outcomes of hepatitis B virus infection].
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 23: 430–433.
20. Cho SW, Cheong JY, Ju YS, Oh do H, Suh YJ, et al. (2008) Human leukocyte
antigen class II association with spontaneous recovery from hepatitis B virus
infection in Koreans: analysis at the haplotype level. J Korean Med Sci 23:
838–844.
21. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al.
(2009) A genome-wide association study identifies variants in the HLA-DP locus
associated with chronic hepatitis B in Asians. Nat Genet 41: 591–595.
22. Wu J, Zhang W, Han LL, Lin CY, Lin H, et al. (2007) [A sero-epidemiological
study on hepatitis B among general population in Beijing]. Chin J Epidemiol
28(6): 555–557.
23. Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype
reconstruction from population data. Am J Hum Genet 68: 978–989.
24. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and
visualization of LD and haplotype maps. Bioinformatics 21: 263–265.
25. Yuen MF, Wong DK, Fung J, Ip P, But D, et al. (2008) HBsAg Seroclearance in
chronic hepatitis B in Asian patients: replicative level and risk of hepatocellular
carcinoma. Gastroenterology 135: 1192–1199.
26. Urbani S, Boni C, Amadei B, Cerioni S, Valli MA, et al. (2005) Acute phase
HBV-specific T cell responses associated with HBV persistence after HBV/
HCV coinfection. Hepatology 41: 826–831.
27. Koulentaki M, Notas G, Petinaki E, Valatas V, Mouzas IA, et al. (2004) Nitric
oxide and pro-inflammatory cytokines in acute hepatitis B. Eur J Intern Med 15:
35–38.
28. Cao T, Desombere I, Vanlandschoot P, Sallberg M, Leroux-Roels G, et al.
(2002) Characterization of HLA DR13-restricted CD4(+) T cell epitopes of
hepatitis B core antigen associated with self-limited, acute hepatitis B. J Gen
Virol 83: 3023–3033.
29. Wu J, Zhang W, Han LL, Lin CY, Lin H, et al. (2007) [A sero-epidemiologiecal
study on hepatitis B among general population in Beijing]. Zhonghua Liu Xing
Bing Xue Za Zhi 28: 555–557.
30. HUGO Pan-Asian SNP Consortium, Abdulla MA, Ahmed I, Assawamakin A,
Bhak J, et al. (2009) Mapping human genetic diversity in Asia. Science 326:
1541–1545.
31. Guo X, Zhang Y, Li J, Ma J, Wei Z, et al. (2010) Strong influence of human
leukocyte antigen (HLA)-DP gene variants on development of persistent chronic
hepatitis B virus carriers in the han Chinese population. Hepatology. 2010
(DOI:10.1002/hep.24048).
32. Diaz G, Amicosante M, Jaraquemada D, Butler RH, Guillen MV, et al. (2003)
Functional analysis of HLA-DP polymorphism: a crucial role for DPbeta
residues 9, 11, 35, 55, 56, 69 and 84–87 in T cell allorecognition and peptide
binding. Int Immunol 15: 565–576.
33. Gaston JS, Goodall JC, Young JL, Young SP (1997) Effect of polymorphism of
the HLA-DPA1 chain on presentation of antigenic peptides. Hum Immunol 54:
40–47.
34. Nicholson I, Varney M, Kanaan C, Grigg A, Szer J, et al. (1997) Alloresponses
to HLA-DP detected in the primary MLR: correlation with a single amino acid
difference. Hum Immunol 55: 163–169.
35. Yu Z, Li Z, Jolicoeur N, Zhang L, Fortin Y, et al. (2007) Aberrant allele
frequencies of the SNPs located in microRNA target sites are potentially
associated with human cancers. Nucleic Acids Res 35: 4535–4541.
36. Rosenberg NA, Huang L, Jewett EM, Szpiech ZA, Jankovic I, et al. (2010)
Genome-wide association studies in diverse populations. Nat Rev Genet 11:
356–366.
37. Ioannidis JP, Thomas G, Daly MJ (2009) Validating, augmenting and refining
genome-wide association signals. Nat Rev Genet 10: 318–329.
Genetic Susceptibility for CHB in Chinese
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e17608